CYduct Diagnostics, Inc. (CYDX)
OTCMKTS · Delayed Price · Currency is USD
0.2521
0.00 (0.00%)
At close: Jul 22, 2025
CYduct Diagnostics Market Cap
CYduct Diagnostics has a market cap or net worth of $1.32 million as of August 26, 2025. Its market cap has decreased by -60.76% in one year.
Market Cap
1.32M
Enterprise Value
n/a
Revenue
344.78K
Ranking
n/a
PE Ratio
9.68
Stock Price
$0.25
Market Cap Chart
Since October 21, 2009, CYduct Diagnostics's market cap has decreased from 13.69M to 1.32M, a decrease of -90.35%. That is a compound annual growth rate of -13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 1.32M | 65.75% |
| Dec 27, 2024 | 797.13K | -69.60% |
| Dec 11, 2023 | 2.62M | -49.00% |
| Dec 29, 2021 | 5.14M | 66.14% |
| Dec 31, 2020 | 3.09M | 37.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |